ERBB2 and breast cancer: The results derived from overall analysis suggested that the overexpression of ALDH1A1 might be related to the enriched-HER2 subtype of breast cancer (ER-PR-HER2+), which is derived from the transformation of mammary late luminal progenitor cells [35,36].